# US 2020/0392479 A1 · Single cell cellular component enrichment from barcoded sequencing libraries

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0392479 A1
- Document ID: US20200392479A1
- Status: Published application
- Kind: A1
- Application number: 16/758,640
- Filed: 2018-10-23
- Published: 2020-12-17
- Earliest claimed: 2017-10-23
- Assignees: The Broad Institute, Inc.; Massachusetts Institute of Technology
- Applicants: The Broad Institute, Inc.; Massachusetts Institute of Technology
- Inventors: Paul Blainey; Navpreet Ranu; Todd Gierahn; Chris Love
- Web page: https://patentgrep.com/patent/US20200392479A1

## CPC

- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- C12N 1/205: Bacterial isolates
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6869: Methods for sequencing
- C40B 30/04: by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
- C40B 40/06: Libraries containing nucleotides or polynucleotides, or derivatives thereof
- C40B 40/10: Libraries containing peptides or polypeptides, or derivatives thereof
- C40B 50/06: Biochemical methods, e.g. using enzymes or whole viable microorganisms
- C12N 2310/20: involving clustered regularly interspaced short palindromic repeats [CRISPR]
- C12R 2001/465: Streptomyces
- C12Y 301/11: Exodeoxyribonucleases producing 5'-phosphomonoesters (3.1.11)
- C12Y 302/02027: Uracil-DNA glycosylase (3.2.2.27)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C40B: COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES (in silico combinatorial libraries of nucleic acids, proteins or peptides G16B35/00; in silico combinatorial chemistry G16C20/60)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12Y: ENZYMES

## Abstract

The present invention relates to the analysis of complex single cell sequencing libraries. Disclosed are methods for enrichment of library members based on the presence of cell-of origin barcodes to identify and concentrate DNA that is relevant to interesting cells or components that would be expensive or difficult to study otherwise. Also, disclosed are methods of capturing cDNA library molecules by use of CRISPR systems, hybridization or PCR. The present invention allows for identifying the properties of rare cells in single cell RNA-seq data and accurately profile them through clustering approaches. Further information on transcript abundances from subpopulations of single cells can be analyzed at a lower sequencing effort. The methods also allow for linking TCR alpha and beta chains at the single cell level.

## Claims

### Claim 1

A method of enriching barcoded constructs from a sequence library generated from a plurality of cells comprising capturing DNA library molecules from the library by targeting one or more cell-identifying barcodes and/or target transcripts.

### Claim 2 (depends on 1)

The method of claim 1, wherein the method is a method of identifying a transcriptome from at least one single cell or a subpopulation of single cells, said method comprising enriching library molecules from the at least one single cell or subpopulation of single cells based on the one or more unique cell-identifying barcodes, wherein the targeted barcodes identify transcripts of single cells represented within the sequencing library.

### Claim 3 (depends on 1, 2)

The method according to claim 1 or 2, comprising:
a) capture of DNA library molecules from the library by targeting one or more target transcripts;
b) sequencing the captured DNA library molecules;
c) identifying cell-identifying barcodes associated with the captured DNA library molecules; and
d) capturing DNA library molecules from the library by targeting the identified cell-identifying barcodes,
whereby DNA constructs associated with single cells expressing one or more target transcripts are enriched.

### Claim 4 (depends on 1, 2, 3)

The method according to any of claims 1 to 3, wherein capture comprises PCR amplification of one or more DNA library molecules with primer pairs complementary to each of the one or more DNA library molecules, wherein the primer pairs comprise one primer comprising a complementary sequence to all or part of a cell-identifying barcode or a complementary sequence to a target transcript sequence for each of the one or more DNA library molecules.

### Claim 5 (depends on 1, 2, 3, 4)

The method according to any of claims 1 to 4, wherein capture comprises PCR amplification of one or more DNA library molecules specific for at least one single cell or subpopulation of single cells.

### Claim 6 (depends on 5)

The method according to claim 5, wherein PCR amplification comprises contacting the library with a 5′ primer and a 3′ primer, wherein the 5′ primer or the 3′ primer comprises a nucleotide sequence that is complementary to the unique barcode of a single cell from the at least one single cell or subpopulation of single cells; and
amplifying the library molecules comprising the unique barcode of the single cell; thereby obtaining a plurality of transcripts from the single cell.

### Claim 7 (depends on 6)

The method of claim 6, wherein:
(a) the 5′ primer comprises a nucleotide sequence that is complementary to a 5′ universal primer site contained in each library molecule and a nucleotide sequence that is complementary to the unique barcode and the 3′ primer comprises a nucleotide sequence that is complementary to a 3′ universal primer site contained in each library molecule;
(b) the 5′ primer comprises a nucleotide sequence that is complementary to a 5′ universal primer site contained in each library molecule and the 3′ primer comprises a nucleotide sequence that is complementary to a 3′ universal primer site contained in each library molecule and a nucleotide sequence that is complementary to the unique barcode;
(c) the 5′ primer comprises a nucleotide sequence that is complementary to a 5′ universal primer site different from the 5′ universal primer site contained in each library molecule and a nucleotide sequence that is complementary to the unique barcode and the 3′ primer comprises a nucleotide sequence that is complementary to a 3′ universal primer site contained in each library molecule; or
(d) the 5′ primer comprises a nucleotide sequence that is complementary to a 5′ universal primer site contained in each library molecule and the 3′ primer comprises a nucleotide sequence that is complementary to a 3′ universal primer site different from the 3′ universal primer site contained in each library molecule and a nucleotide sequence that is complementary to the unique barcode.

### Claim 8 (depends on 5)

The method according to claim 5, wherein the library molecules are pair-end DNA constructs comprising a first priming site outside of a single cell barcode at one end of the construct and a second priming site at the other end of the construct, and wherein PCR amplification comprises a first primer specific for the first priming site and single cell barcode and a second primer specific for the second priming site.

### Claim 9 (depends on 4, 5, 6, 7, 8)

The method according to any of claims 4 to 8, wherein at least one primer for amplification of DNA library molecules comprises a label, wherein amplification products may be separated from the library by capturing amplification products comprising the label.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the label comprises biotin.

### Claim 11 (depends on 10)

The method according to claim 10, wherein the separating of the labeled amplification product from the library comprises contacting the biotin-labeled amplification product with streptavidin.

### Claim 12 (depends on 11)

The method according to claim 11, wherein the streptavidin is conjugated to a bead.

### Claim 13 (depends on 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method according to any of claims 4 to 12, wherein the library molecules comprise uracil.

### Claim 14 (depends on 13)

The method according to claim 13, further comprising:
treating the amplified library molecules with uracil DNA glycosylase (UDG) and exonuclease; and
amplifying the library molecules a second time.

### Claim 15 (depends on 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method according to any of claims 4 to 12, wherein amplifying the library molecules from the single cell comprises:
providing a single cell library from a plurality of cells, with library molecules from each cell comprising a barcode, and wherein the library comprises uracil;
amplifying the transcripts having the barcode by contacting the library of transcripts with a 5′ primer and a 3′ primer, wherein the 5′ primer or the 3′ primer comprises a nucleotide sequence that is complementary to the barcode of the single cell and a polymerase that does not recognize uracil;
treating the amplified transcripts with uracil DNA glycosylase (UDG) and exonuclease; and
amplifying the transcripts treated with uracil DNA glycosylase (UDG) and exonuclease.

### Claim 16 (depends on 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)

The method according to any of claims 4 to 15, further comprising sequencing the amplified library molecules.

### Claim 17 (depends on 1, 2, 3, 4)

The method according to any of claims 1 to 4, wherein capture comprises hybridization of DNA library molecules to oligonucleotides specific for target cell-identifying barcodes or target transcript sequences; and separating the oligonucleotides hybridized to the target cell-identifying barcodes or target transcript sequences from the library.

### Claim 18 (depends on 17)

The method according to claim 17, wherein hybridization is performed in solution.

### Claim 19 (depends on 17, 18)

The method according to claim 17 or 18, wherein the oligonucleotides comprise a label, wherein DNA library molecules may be separated from the library by capturing hybridized DNA library molecules comprising the label.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the label comprises biotin.

### Claim 21 (depends on 20)

The method according to claim 20, wherein the separating of the labeled oligonucleotide hybridized to the target library molecules comprises contacting the biotin-labeled oligonucleotide hybridized to the target library molecules with streptavidin.

### Claim 22 (depends on 21)

The method according to claim 21, wherein the streptavidin is conjugated to a bead.

### Claim 23 (depends on 17, 18, 19, 20, 21, 22)

The method according to any of claims 17 to 22, further comprising PCR amplification of hybridized library molecules.

### Claim 24 (depends on 17, 18, 19, 20, 21, 22, 23)

The method according to any of claims 17 to 23, further comprising sequencing the hybridized library molecules.

### Claim 25 (depends on 1, 2, 3, 4)

The method according to any of claims 1 to 4, wherein capture comprises contacting the library with a CRISPR system, wherein the CRISPR system comprises CRISPR guide RNAs complementary to target cell-identifying barcodes or target transcript sequences.

### Claim 26 (depends on 25)

The method according to claim 25, wherein contacting the library with a CRISPR system is performed in solution.

### Claim 27 (depends on 25, 26)

The method according to claim 25 or 26, wherein the CRISPR system comprises an enzymatically inactive CRISPR enzyme.

### Claim 28 (depends on 25, 26, 27)

The method according to claims 25 to 27, wherein the CRISPR system comprises an RNA guided DNA targeting or RNA-targeting CRISPR enzyme.

### Claim 29 (depends on 28)

The method according to claim 28, wherein the CRISPR enzyme is Cas9, Cpf1, or Cas13.

### Claim 30 (depends on 25, 26, 27, 28, 29)

The method according to any of claims 25 to 29, wherein the captured DNA library molecules are isolated on a solid support and released from the solid support by treatment with RNase, proteinase, or denaturing conditions.

### Claim 31 (depends on 25, 26, 27, 28, 29, 30)

The method according to any of claims 25 to 30, further comprising sequencing the captured library molecules.

### Claim 32

A sequencing method for identifying a single cell transcriptome in at least one single cell or subpopulation of single cells within a population of cells comprising:
a) enriching library molecules from a single cell RNA sequencing (scRNA-seq) library for at least one single cell or subpopulation of single cells, wherein the library molecules comprise cell-identifying barcodes; and
b) sequencing the enriched library molecules, whereby gene expression is determined for the at least one single cell or subpopulation of single cells.

### Claim 33 (depends on 32)

The method according to claim 32, further comprising step (a′) before step (a), wherein step (a′) comprises performing single cell RNA sequencing on a population of cells thereby generating a library of barcoded library molecules and a dataset comprising barcodes and natural sequences, wherein barcodes are identified for at least one single cell or subpopulation of single cells of interest from the population of cells.

### Claim 34 (depends on 32, 33)

The method according to claim 32 or 33, wherein the single cell RNA sequencing in step (a′) comprises deep sequencing of the library.

### Claim 35 (depends on 32, 33, 34)

The method according to any of claims 32 to 34, wherein the at least one single cell or subpopulation of single cells comprises T cells, B cells, macrophages, neutrophils, dendritic cells, megakaryocytes, monocytes, basophils, or eosinophils and barcodes specific to T cells, B cells, macrophages, neutrophils, dendritic cells, megakaryocytes, monocytes, basophils, or eosinophils are enriched.

### Claim 36 (depends on 35)

The method according to claim 35, wherein T cell receptor (TCR) or B cell receptor (BCR) pairs are determined.

### Claim 37 (depends on 35, 36)

The method according to claim 35 or 36, wherein the single cell RNA-seq library is generated from a tumor sample comprising tumor infiltrating lymphocytes (TIL).

### Claim 38

A sequencing method for identifying a single cell transcriptome in at least one single cell or subpopulation of single cells within a population of cells, wherein the at least one single cell or subpopulation of cells express or lack expression of a subset of transcripts of interest comprising:
a) determining expression of the transcripts of interest in a single cell library from the population of cells, wherein the library molecules comprise cell-identifying barcodes;
b) identifying barcodes associated with expression or lack of expression of the transcripts of interest in the single cell library;
c) enriching library molecules comprising the cell-identifying barcodes associated with expression of the transcripts of interest from the single cell library; and
d) sequencing the enriched library molecules, whereby a single cell transcriptome is identified for at least one single cell or subpopulation of single cells expressing a subset of transcripts of interest.

### Claim 39

A method for identifying a barcode associated with transcripts from a single cell in a library of transcripts comprising:
providing a library of transcripts from a plurality of cells, with transcripts from each cell comprising a barcode;
contacting the library of transcripts with a labeled oligonucleotide that is complementary to a target transcript encoding a specific T cell receptor or a specific B cell receptor under conditions sufficient for the labeled oligonucleotide to hybridize with the target transcript; and
separating the labeled oligonucleotide hybridized to the target transcript from the library of transcripts;
thereby separating cell barcodes of cells expressing the T cell receptor or B cell receptor.

### Claim 40 (depends on 39)

The method according to claim 39, wherein the single cell is a T cell or a B cell.

### Claim 41

A method for isolating a transcriptome of a single cell from a library of transcripts comprising:
providing a library of transcripts from a plurality of cells, with transcripts from each cell comprising a unique barcode;
detecting and separating the transcripts comprising the unique barcode of the single cell; and
sequencing the transcripts; wherein:
(i) the library of transcripts is generated from 50,000 cells or more;
(ii) transcripts that occur at a frequency of less than 1:108 to 1:109 in the library of transcripts are identified; or
(iii) the single cell is a cell type that occur at a frequency of less than 1%-0.001% in the plurality of cells.

### Claim 42 (depends on 41)

The method according to claim 41, wherein detecting and separating the transcripts comprising the unique barcode of the single cell comprises:
isolating a target transcript from the library of transcripts;
sequencing the barcode in the target transcript(s); and
amplifying the transcripts comprising the barcode of the single cell.

### Claim 43

The method according to any of the preceding claims, wherein the captured library molecules are sequenced by pyrosequencing, single-molecule real-time sequencing, ion torrent sequencing, sequencing by synthesis, sequencing by degradation, sequencing by ligation, sequencing by hybridization, Sanger sequencing or by the use of a biological or a solid state nanopore.

### Claim 44

The method according to any of the preceding claims, wherein the sequencing of the captured library molecules comprises a sequencing depth greater than about 5000 reads per cell.

### Claim 45

The method according to any of the preceding claims, wherein the sequencing of the captured library molecules comprises a sequencing depth less than about 5000 reads per cell.

### Claim 46

The method according to any of the preceding claims, further comprising counting the unique barcodes that are identified from sequencing of a single cell library or enriched single cell library as a measure of the number of cells that express a target transcript or subset of transcripts, wherein each unique barcode identifies a single cell.

### Claim 47

The method according to any of the preceding claims, wherein the library is a single cell RNA sequencing (scRNA-seq) library.

### Claim 48 (depends on 47)

The method of claim 47, wherein the single cell RNA sequencing library is generated by 3′ digital gene expression (DGE), SMART-seq2, SeqWell, droplet microfluidic barcoding, split and pool barcoding, or combinatorial indexing.

### Claim 49

The method according to any of the preceding claims, wherein the barcode is 10-20 nucleotides in length.

### Claim 50

The method according to any of the preceding claims, wherein the library is generated from 50,000 cells or more.

### Claim 51

The method according to any of the preceding claims, wherein transcripts that occur at a frequency of less than 1:108 to 1:109 in the library are identified.

### Claim 52

The method according to any of the preceding claims, wherein the single cell is a cell type that is present at a frequency of less than 1%-0.001%.

### Claim 53

The method according to any of the preceding claims, wherein the target transcript encodes a cytokine, a T cell receptor, a B cell receptor, a pathogen transcript, a chemokine, a circulating tumor cell marker, or a cell activation marker.

### Claim 54 (depends on 53)

The method of claim 53, wherein the circulating tumor cell marker is selected from EpCAM, EphB4, EGFR, CEA, HER2, or MUC-1.

### Claim 55 (depends on 53)

The method of claim 53, wherein the cell activation marker is selected from CD154, CD137, CD134, CD278, or CD69.

### Claim 56

The method according to any of the preceding claims, wherein the at least one single cell or subpopulation of single cells comprises a tumor cell, a T cell, a B cell, an NK cell, a cytokine-secreting cell, a dendritic cell, or a pathogen-infected cell.

### Claim 57

The method according to any of the preceding claims, wherein the library is generated from a population of cells comprising cultured cells, some or all of a tumor, a tissue sample, a bone marrow sample, or a blood sample.

### Claim 58 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57)

The method according to any of claims 32 to 57, wherein enriching, isolating or separating library molecules comprises any method according to claims 1 to 31.
